Navigation Links
Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights
Date:10/23/2008

SAN DIEGO, Oct. 23 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS), a clinical-stage biopharmaceutical company dedicated to improving patient care by developing novel medicines in the areas of hepatitis C and oncology, today reported its financial results and highlights for the third quarter ended September 30, 2008.

"We continue to make rapid progress in both of our hepatitis C development programs," said Steve Worland Ph.D., President and CEO of Anadys. "We completed our first clinical study of ANA598 in healthy volunteers and have now completed the healthy volunteer portion of our ongoing ANA773 study. For both programs, we are very encouraged by the data and look forward to initiating patient dosing this quarter."

Financial Results

As of September 30, 2008, the Company's cash, cash equivalents and securities available-for-sale totaled $34.4 million.

During the third quarter of 2008 the Company had no revenue, compared to $21.5 million for the same quarter of 2007. The revenue in the third quarter of 2007 was primarily derived from the recognition of previously deferred revenue associated with an upfront payment and a milestone payment under a prior collaboration.

Research and development expenses were $7.6 million for the third quarter of 2008 and 2007. During the third quarter of 2008, cost savings derived from Anadys' completed strategic restructuring and associated termination of prior development programs were offset by a significant increase in ANA598 development costs.

General and administrative expenses were $2.1 million for the third quarter of 2008, compared to $2.4 million for the third quarter of 2007. The $0.3 million decrease primarily resulted from cost savi
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
2. Anadys Pharmaceuticals to Report Third Quarter 2007 Financial Results
3. Anadys Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw Healthcare Conference
4. Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
5. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
6. Anadys Pharmaceuticals to Present at the JPMorgan Healthcare Conference
7. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
8. Anadys Pharmaceuticals to Report Fourth Quarter and Year-End 2007 Financial Results
9. Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference
10. Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients
11. Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... CAMBRIDGE, Mass., Dec. 11 Gwathmey, ... company specializing in cancer, staph aureus, and cardiovascular ... Pre-clinical Services announced today that Rosalie Dunn, Ph.D., ... Dr. Dunn has over 28 years of experience ... Prior to joining Gwathmey, Dr. Dunn managed ...
(Date:12/10/2009)... HUNTERSVILLE, N.C., Dec. 10 Microban ... antimicrobial product protection, has partnered with Sharp ... division of Sharp Electronics, to incorporate it,s ... new printing calculators. Infused into the calculator ... protection inhibits the growth of damaging bacteria ...
(Date:12/10/2009)... Dec. 10 Newly published research, ... Stem Cell Institute (NESCI) in the journal ... of eight patients with "Limbal Stem Cell ... cells without the need of suppressing their ... ,, LSCD is a painful, blinding disease ...
(Date:12/10/2009)... Vivakor, Inc. (OTC Bulletin Board: ... into an exclusive, $5 million license agreement ... ( www.regeneca.com ). The agreement exclusively ... new cutting-edge nutraceutical formulation developed by Vivakor ... formulations by Vivakor for Regeneca. Under the ...
Breaking Biology Technology:Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2Microban Signs Exclusive Agreement with Sharp Electronics to Launch Calculators with New Microban(R) 3G Silver(TM) Antimicrobial Technology 2Successful Stem Cell Therapy for Treatment of Eye Disease 2Successful Stem Cell Therapy for Treatment of Eye Disease 3Successful Stem Cell Therapy for Treatment of Eye Disease 4Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3
... Covance Inc. (NYSE:,CVD) today announced that it will ... Device Conference on February 6th,at 9:20 am ET. Investors ... http://www.covance.com . In order to register and download any ... with headquarters in Princeton, New Jersey, is one of ...
... Bulletin Board: NILT), announced today that Peter M. Strumph,Chief ... Investor Conference,at the Waldorf-Astoria Hotel in New York City ... Strumph will provide an overview of Nile and an,update ... be webcast live and can be accessed by visiting,the ...
... /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq:,ONTY) (TSX: ONY), a ... products for the treatment of cancer, today,announced the ... http://www.oncothyreon.com ., "We are excited about our ... website, which provides additional information about our,product pipeline ...
Other Biology Technology:Nile Therapeutics, Inc. to Present at Upcoming BIO CEO & Investor Conference 2
(Date:12/14/2009)... December 10, 2009If you are spending the holidays with ... whether you would be better off with another family, ... , A research team from McMaster University and the ... cichlids, a species that lives in groups, members make ... results appear in the current issue of Biology ...
(Date:12/14/2009)... As good as laparoscopy is in preventing some of the ... drawbacks, including reduced blood flow and organ dysfunction. Laparoscopy is ... incisions. , By adding another gas ... during laparoscopy, researchers at Duke University Medical Center have found ... , The gas ethyl nitrite (ENO) helped to open ...
(Date:12/13/2009)... CADecember 10, 2009Researchers at The Scripps Research Institute ... single protein from an ancient family of enzymes ... body. In addition to providing guidance for understanding ... a theoretical underpinning for the protein,s possible use ... , The research was published in the December ...
Breaking Biology News(10 mins):Gas improves blood flow and organ status during minimally invasive surgery 2Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3DJ AM 3A Why He Went Too Far Phoenix House Thought Piece for National Recovery Month by Dr Deni Carise 56569 1DJ AM 3A Why He Went Too Far Phoenix House Thought Piece for National Recovery Month by Dr Deni Carise 56569 2DJ AM 3A Why He Went Too Far Phoenix House Thought Piece for National Recovery Month by Dr Deni Carise 56569 3DJ AM 3A Why He Went Too Far Phoenix House Thought Piece for National Recovery Month by Dr Deni Carise 56569 4Doctors Stand Together Against Government Takeover of Healthcare on Sept 10th in DC 56566 1Thomson Joins Brooks Kushman 3B Strengthens Los Angeles Presence 13942 1Thomson Joins Brooks Kushman 3B Strengthens Los Angeles Presence 13942 2
... Clinic-led research collaboration has discovered that the protein MDC1 ... begin. Once amplified, even low-level damage signals become strong ... the injury is most tractable to repair. , ... this finding, which appears in the January 20 issue ...
... of the humpback whale are among the most complex in ... have their own syntax that uses sound units to build ... for hours. , Until now, only humans have demonstrated the ... research, published online in the March 2006 issue of the ...
... at the University at Buffalo and the University ... two intracellular events, both stimulated by the same ... , The broad implication of the findings may ... underpinnings of mammalian behavior, according to the researchers. ...
Other Biology News:Mayo Clinic collaboration discovers protein amplifies DNA injury signals 2Mayo Clinic collaboration discovers protein amplifies DNA injury signals 3Warbling whales speak a language all their own 2Warbling whales speak a language all their own 3Manipulating single cell receptor alters animal behavior 2Manipulating single cell receptor alters animal behavior 3